retatrutide glp 1 Promises Big Weight Loss, but Safety Remains a Question Retatrutide vs Semaglutide and Tirzepatide:

The Medicines and Healthcare products Regulatory Agency (MHRA) and the European Medicines Agency (EMA) have not issued specific warnings about this combination, but the absence of a formal contraindication does not equate to established safety

Access to More Than One Medication Option Semaglutide and tirzepatide work differently, and people respond to each one differently too

However, these side effects are generally mild and tend to diminish over time as the body adjusts to the medication

I., Udell, J

This was higher than the drop-out rates observed in the trials within the COR programme, which were around 4050% [20]

Folks stay on retatrutide longer since it causes less nausea than other drugs